Logo image of CRE.CA

CRITICAL ELEMENTS LITHIUM CO (CRE.CA) Stock Fundamental Analysis

TSX-V:CRE - TSX Venture Exchange - CA22675W1077 - Common Stock - Currency: CAD

0.57  +0.02 (+3.64%)

Fundamental Rating

3

Overall CRE gets a fundamental rating of 3 out of 10. We evaluated CRE against 797 industry peers in the Metals & Mining industry. The financial health of CRE is average, but there are quite some concerns on its profitability. CRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CRE was profitable.
In the past year CRE has reported a negative cash flow from operations.
CRE had negative earnings in each of the past 5 years.
CRE had a negative operating cash flow in each of the past 5 years.
CRE.CA Yearly Net Income VS EBIT VS OCF VS FCFCRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

CRE's Return On Assets of 11.51% is amongst the best of the industry. CRE outperforms 94.35% of its industry peers.
Looking at the Return On Equity, with a value of 12.36%, CRE belongs to the top of the industry, outperforming 92.72% of the companies in the same industry.
Industry RankSector Rank
ROA 11.51%
ROE 12.36%
ROIC N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
CRE.CA Yearly ROA, ROE, ROICCRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRE.CA Yearly Profit, Operating, Gross MarginsCRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for CRE remains at a similar level compared to 1 year ago.
The number of shares outstanding for CRE has been increased compared to 5 years ago.
The debt/assets ratio for CRE has been reduced compared to a year ago.
CRE.CA Yearly Shares OutstandingCRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRE.CA Yearly Total Debt VS Total AssetsCRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CRE has an Altman-Z score of 11.66. This indicates that CRE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CRE (11.66) is better than 74.28% of its industry peers.
CRE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, CRE is in line with its industry, outperforming 55.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.66
ROIC/WACCN/A
WACCN/A
CRE.CA Yearly LT Debt VS Equity VS FCFCRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 15.42 indicates that CRE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 15.42, CRE belongs to the top of the industry, outperforming 89.59% of the companies in the same industry.
CRE has a Quick Ratio of 15.42. This indicates that CRE is financially healthy and has no problem in meeting its short term obligations.
CRE has a better Quick ratio (15.42) than 89.59% of its industry peers.
Industry RankSector Rank
Current Ratio 15.42
Quick Ratio 15.42
CRE.CA Yearly Current Assets VS Current LiabilitesCRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

CRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 312.67%, which is quite impressive.
EPS 1Y (TTM)312.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%927.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 88.11% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-22%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRE.CA Yearly Revenue VS EstimatesCRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 100M 200M 300M 400M 500M
CRE.CA Yearly EPS VS EstimatesCRE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.40, which indicates a very decent valuation of CRE.
Based on the Price/Earnings ratio, CRE is valued cheaply inside the industry as 94.73% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CRE is valued rather cheaply.
CRE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 11.4
Fwd PE N/A
CRE.CA Price Earnings VS Forward Price EarningsCRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200 -250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRE.CA Per share dataCRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

CRE's earnings are expected to grow with 236.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.48%
EPS Next 3Y236.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRITICAL ELEMENTS LITHIUM CO

TSX-V:CRE (7/11/2025, 7:00:00 PM)

0.57

+0.02 (+3.64%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-07 2025-07-07
Earnings (Next)11-05 2025-11-05/amc
Inst Owners3.23%
Inst Owner ChangeN/A
Ins Owners4.28%
Ins Owner ChangeN/A
Market Cap124.17M
Analysts83.08
Price Target1.49 (161.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.4
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.05
EY8.77%
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.51%
ROE 12.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8570.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.42
Quick Ratio 15.42
Altman-Z 11.66
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12312.4%
Cap/Depr(5y)9260.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)312.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%927.91%
EPS Next Y-22%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-322.62%
EBIT Next 3Y132.14%
EBIT Next 5Y123.6%
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.73%
OCF growth 3YN/A
OCF growth 5YN/A